Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PTH (1-34) Gel in mild to moderate plaque psoriasis
NCT00593177Phase 2Completed
- Sponsor
- Manhattan Pharmaceuticals, Inc.
- Start
- Oct 2007
- Primary completion
- Jun 2008
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of Osteofortil in plaque psoriasis, sponsored by Manhattan Pharmaceuticals, Inc.. Started Oct 2007; status: completed.
02
Drugs
Osteofortil
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT00593177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00593177.